MedTrace Logo

Effects of Intraoperative Esmolol on Post-mastectomy Pain Syndrome

NCT03965442 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2019-05-29

No results posted yet for this study

Summary

Chronic postoperative pain is an entity that is usually neglected by anesthetists, but several studies show that the choice of anesthetic technique may interfere with this prevalence. Esmolol is a selective beta-blocker of ultra fast duration that has been studied as a perioperative venous adjuvant with antihyperalgesic and opioid sparing action. The investigators ventured the possibility of this anti-hyperalgesic effect attenuating the chronic pain syndrome post-mastectomy.

Conditions

  • Post-mastectomy Pain Syndrome

Interventions

DRUG

Control

Patients who underwent mastectomy under standard general anesthesia

DRUG

Esmolol

Patients who underwent mastectomy under general anesthesia with esmolol infusion

Sponsors & Collaborators

  • Hospital de Base

    lead OTHER

Principal Investigators

  • Fabricio T Mendonça, MD · Hospital de Base do Distrito Federal

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-07-31
Completion
2019-07-31
FDA Drug
Yes

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03965442 on ClinicalTrials.gov